Medical Oncology, Prostate Cancer
BA: Brown University, 1989; M.Phil: Oxford University, 1991; MD, Harvard Medical School, 1998; M.Sc, Harvard School of Public Health; Intern/Resident in Medicine: Massachusetts General Hospital, 1998-2001; Clinical Fellow in Oncology: Memorial Sloan Kettering Cancer Center, 2002-2005; Assistant Member: Memorial Sloan Kettering Cancer Center, 2005-2011; Associate Member: Memorial Sloan Kettering Cancer Center, 2011-2012; Associate Professor of Medicine, Urology, and Public Health: University of North Carolina, 2012-2016; Director, Cancer Outcomes Research Program: UNC Lineberger Comprehensive Cancer Center, 2012-present; Professor of Medicine, Urology, and Public Health:, University of North Carolina, 2016-present; Associate Chief: Division of Oncology, Department of Medicine, UNC, 2016-present; Richard M. Goldberg Distinguished Professor in Medical Oncology: University of North Carolina, 2018-present.
Research and Clinical Interests
I am a medical oncologist focused on the treatment of men with prostate cancer. I have led and participated in many of the national guidelines on the treatment of this disease. The goal of my research is to improve the patient-centeredness of cancer care and drug development. My research team has developed tools with the National Cancer Institute that are widely used to collect symptom information directly from patients.
I believe deeply in the importance of listening to patients, communicating options clearly, and coming to shared decisions about treatment. Quality of life is one of my highest goals for patients and families. I try my best to understand the values and experiences of patients, and to provide support as well as needed information. I appreciate that everyone makes unique decisions for their own situation and beliefs. I work with an outstanding team of colleagues who help with each patient, including nurse “navigators” who help patients and families understand the complexities of receiving cancer care; pharmacists who review drugs and explain side effects; and counselors when needed. At UNC, we have many clinical trials that may be an option for patients, depending on their situation, and it is my goal to offer patients the best and most up-to-date treatment options.